🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/10/2016 | 59,84 | 59,84 | 58,16 | 58,23 | -1,90% | 2,81% | 529.631 |
| 26/10/2016 | 58,29 | 59,99 | 57,82 | 59,36 | +1,99% | 3,72% | 641.521 |
| 25/10/2016 | 58,45 | 59,22 | 57,97 | 58,20 | -0,74% | 2,13% | 322.844 |
| 24/10/2016 | 58,33 | 59,41 | 58,26 | 58,63 | +0,51% | 1,98% | 386.804 |
| 21/10/2016 | 59,52 | 59,76 | 58,05 | 58,33 | -2,23% | 2,87% | 383.919 |
| 20/10/2016 | 58,37 | 60,33 | 57,89 | 59,66 | +1,43% | 4,18% | 558.165 |
| 19/10/2016 | 59,12 | 59,44 | 58,25 | 58,82 | -0,26% | 2,02% | 312.264 |
| 18/10/2016 | 59,01 | 59,85 | 58,63 | 58,98 | +1,21% | 2,07% | 339.035 |
| 17/10/2016 | 57,58 | 58,89 | 56,91 | 58,27 | +0,29% | 3,43% | 829.232 |
| 14/10/2016 | 60,03 | 60,06 | 58,03 | 58,10 | -2,92% | 3,38% | 483.465 |
| 13/10/2016 | 59,41 | 60,26 | 58,75 | 59,85 | +0,28% | 2,53% | 416.620 |
| 12/10/2016 | 61,48 | 62,06 | 59,37 | 59,68 | -2,70% | 4,38% | 673.100 |
| 11/10/2016 | 62,71 | 63,41 | 61,22 | 61,34 | -3,21% | 3,50% | 490.358 |
| 10/10/2016 | 61,30 | 63,62 | 61,20 | 63,37 | +4,38% | 3,94% | 542.135 |
| 07/10/2016 | 61,33 | 61,91 | 60,21 | 60,71 | -1,24% | 2,77% | 783.066 |
| 06/10/2016 | 62,45 | 62,94 | 61,17 | 61,47 | -2,71% | 2,83% | 658.833 |
| 05/10/2016 | 63,88 | 64,40 | 62,96 | 63,18 | +0,71% | 2,26% | 570.828 |
| 04/10/2016 | 63,63 | 64,23 | 62,59 | 62,74 | -1,22% | 2,58% | 373.499 |
| 03/10/2016 | 63,26 | 63,67 | 62,57 | 63,51 | -0,24% | 1,75% | 541.013 |
| 30/09/2016 | 64,12 | 64,12 | 62,88 | 63,67 | +0,05% | 1,94% | 554.478 |
| 29/09/2016 | 63,74 | 63,94 | 62,86 | 63,64 | -0,42% | 1,68% | 764.952 |
| 28/09/2016 | 62,15 | 64,15 | 61,96 | 63,91 | +2,81% | 3,52% | 1.319.109 |
| 27/09/2016 | 68,00 | 68,15 | 60,65 | 62,16 | -11,89% | 11,04% | 4.534.887 |
| 26/09/2016 | 72,15 | 72,49 | 70,40 | 70,55 | -2,32% | 2,90% | 354.744 |
| 23/09/2016 | 73,43 | 73,64 | 72,19 | 72,23 | -2,01% | 1,97% | 308.738 |
| 22/09/2016 | 73,14 | 73,89 | 72,32 | 73,71 | +1,03% | 2,14% | 327.493 |
| 21/09/2016 | 73,47 | 74,02 | 71,19 | 72,96 | -0,15% | 3,85% | 635.109 |
| 20/09/2016 | 72,55 | 73,52 | 72,06 | 73,08 | +1,33% | 2,00% | 453.809 |
| 19/09/2016 | 72,69 | 72,99 | 71,89 | 72,11 | +0,05% | 1,51% | 394.338 |
| 16/09/2016 | 71,83 | 72,51 | 71,33 | 72,08 | +0,40% | 1,64% | 657.711 |